- Home
- OIS vs ALDX Comparison
OIS vs ALDX Comparison
Compare OIS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OIS
- ALDX
- Stock Information
- Founded
- OIS 1995
- ALDX 2004
- Country
- OIS United States
- ALDX United States
- Employees
- OIS N/A
- ALDX N/A
- Industry
- OIS Metal Fabrications
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- OIS Industrials
- ALDX Health Care
- Exchange
- OIS Nasdaq
- ALDX Nasdaq
- Market Cap
- OIS 330.1M
- ALDX 304.9M
- IPO Year
- OIS 2001
- ALDX 2014
- Fundamental
- Price
- OIS $5.42
- ALDX $6.71
- Analyst Decision
- OIS Buy
- ALDX Strong Buy
- Analyst Count
- OIS 3
- ALDX 2
- Target Price
- OIS $6.50
- ALDX $10.00
- AVG Volume (30 Days)
- OIS 1.0M
- ALDX 666.8K
- Earning Date
- OIS 04-25-2025
- ALDX 05-01-2025
- Dividend Yield
- OIS N/A
- ALDX N/A
- EPS Growth
- OIS N/A
- ALDX N/A
- EPS
- OIS N/A
- ALDX N/A
- Revenue
- OIS $692,588,000.00
- ALDX N/A
- Revenue This Year
- OIS $3.40
- ALDX N/A
- Revenue Next Year
- OIS $4.88
- ALDX N/A
- P/E Ratio
- OIS N/A
- ALDX N/A
- Revenue Growth
- OIS N/A
- ALDX N/A
- 52 Week Low
- OIS $3.91
- ALDX $2.75
- 52 Week High
- OIS $6.53
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- OIS 58.51
- ALDX 57.30
- Support Level
- OIS $4.68
- ALDX $6.22
- Resistance Level
- OIS $5.48
- ALDX $7.20
- Average True Range (ATR)
- OIS 0.22
- ALDX 0.53
- MACD
- OIS 0.06
- ALDX -0.01
- Stochastic Oscillator
- OIS 86.36
- ALDX 79.59
About OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore/Manufactured Products, Well Site Services and Downhole Technologies. It erns maximum revenue from Offshore/Manufactured Products.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.